Article metrics
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1380 Synergistic anti-tumor effect of Allocetra-OTS, a cellular immune-therapy, in combination with immune checkpoint inhibitors/chemotherapy/CAR T, through in-vivo reprogramming of macrophages